Abstract:OBJECTIVES:Heme oxygenase-1 is inducible in cardiomyocytes in response to stimuli such as oxidative stress and plays critical roles in combating cardiac hypertrophy and injury. Signal transducer and activator of transcription 3 plays a pivotal role in heme oxygenase-1-mediated protection against liver and lung injuries under oxidative stress. We hypothesized that propofol, an anesthetic with antioxidant capacity, may attenuate hyperglycemia-induced oxidative stress in cardiomyocytes via enhancing heme oxygenase-1 activation and ameliorate hyperglycemia-induced cardiac hypertrophy and apoptosis via heme oxygenase-1/signal transducer and activator of transcription 3 signaling and improve cardiac function in diabetes. DESIGN:Treatment study. SETTING:Research laboratory. SUBJECTS:Sprague-Dawley rats. INTERVENTIONS:In vivo and in vitro treatments. MEASUREMENTS AND MAIN RESULTS:At 8 weeks of streptozotocin-induced type 1 diabetes in rats, myocardial 15-F2t-isoprostane was significantly increased, accompanied by cardiomyocyte hypertrophy and apoptosis and impaired left ventricular function that was coincident with reduced heme oxygenase-1 activity and signal transducer and activator of transcription 3 activation despite an increase in heme oxygenase-1 protein expression as compared to control. Propofol infusion (900 μg/kg/min) for 45 minutes significantly improved cardiac function with concomitantly enhanced heme oxygenase-1 activity and signal transducer and activator of transcription activation. Similar to the changes seen in diabetic rat hearts, high glucose (25 mmol/L) exposure for 48 hours led to cardiomyocyte hypertrophy and apoptosis, both in primary cultured neonatal rat cardiomyocytes and in H9c2 cells compared to normal glucose (5.5 mmol/L). Hypertrophy was accompanied by increased reactive oxygen species and malondialdehyde production and caspase-3 activity. Propofol, similar to the heme oxygenase-1 inducer cobalt protoporphyrin, significantly increased cardiomyocyte heme oxygenase-1 and p-signal transducer and activator of transcription protein expression and heme oxygenase-1 activity and attenuated high-glucose-mediated cardiomyocyte hypertrophy and apoptosis and reduced reactive oxygen species and malondialdehyde production (p < 0.05). These protective effects of propofol were abolished by heme oxygenase-1 inhibition with zinc protoporphyrin and by heme oxygenase-1 or signal transducer and activator of transcription 3 gene knockdown. CONCLUSIONS:Heme oxygenase-1/signal transducer and activator of transcription 3 signaling plays a critical role in propofol-mediated amelioration of hyperglycemia-induced cardiomyocyte hypertrophy and apoptosis, whereby propofol improves cardiac function in diabetic rats.

Role of PI3K/Akt signaling pathway in reduction of hypoxia-reoxygenation-induced injury to cardiomyocytes by propofol postconditioning in rats

The Role of PI3K/Akt Signal Pathway in the Protective Effects of Propofol on Intestinal and Lung Injury Induced by Intestinal Ischemia/reperfusion

Propofol ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction via heme oxygenase-1/signal transducer and activator of transcription 3 signaling pathway in rats.

Role of HIF-1.ALPHA./HKII Signaling Pathway in Inhibition of Hypoxia/reoxygenation-Induced Apoptosis in Rat Cardiomyocytes by Hypoxic Preconditioning

Propofol Inhibits Ischemia/Reperfusion-Induced Cardiotoxicity Through The Protein Kinase C/Nuclear Factor Erythroid 2-Related Factor Pathway

Hydromorphone postconditioning attenuates myocardial ischemia/reperfusion-induced apoptosis in rats through PI3K/AKT pathway

The Role of PI3/Akt Signaling Pathway in the Protective Effect of Morphine Postconditioning on Myocardium Against Ischemiareperfusion Injury in Rats

Protective effect of proanthocyanidins on anoxia-reoxygenation injury of myocardial cells mediated by the PI3K/Akt/GSK-3β pathway and mitochondrial ATP-sensitive potassium channel.

Effect of Propofol on Microtubule-Associated Protein 1 Light Chain 3 Following Myocardial Ischemia/reperfusion Injury of Rats

Propofol Protects Myocardium From Ischemia/Reperfusion Injury by Inhibiting Ferroptosis Through the AKT/p53 Signaling Pathway

Cox-2 Negatively Affects the Protective Role of Propofol against Hypoxia/Reoxygenation Induced Cardiomyocytes Apoptosis through Suppressing Akt Signaling.

Effects of propofol on Akt activity in rats with focal cerebral ischemia-reperfusion injury

Propofol Prevents Cerebral Ischemia-Triggered Autophagy Activation and Cell Death in the Rat Hippocampus Through the NF-κB/p53 Signaling Pathway

Hypoxic preconditioning of cardiomyocytes and cardioprotection: phophorylation of HIF-1alpha induced by p42/p44 mitogen-activated protein kinases is involved.

Role of AMPK singal pathway in propofol against transient cerebral ischemia/reperfusion injury of ;aged rats

Role of hypoxia-inducible factor-1α in the prevention of cardiomyocyte injury induced by hypoxic preconditioning

Propofol Through Upregulating Caveolin-3 Attenuates Post-Hypoxic Mitochondrial Damage and Cell Death in H9C2 Cardiomyocytes During Hyperglycemia

Role of GSK-3β in the Protective Effect of Propofol Pretreatment Against Hepatic Ischemia-Reperfusion Injury and Oxidative Stress in Rats

Protective effect of propofol preconditioning on ischemia-reperfusion injury in human hepatocyte.

Propofol protects hepatic L02 cells from hydrogen peroxide-induced apoptosis via activation of extracellular signal-regulated kinases pathway.

PI3K/Akt Signaling Pathway Involved in Cardioprotection of Preconditioning with High Mobility Group Box 1 Protein During Myocardial Ischemia and Reperfusion